Want to see AU:NHF full AI Analyst Report?
Top Page
NIB Holdings Ltd
(Sydney:NHF)
Select Model
Select Model
Rating:68Neutral
Price Target:
AU$7.50
▲(9.97% Upside)
Action:Downgraded
Date:08/25/26
The score is driven primarily by solid financial performance (healthy balance sheet, recurring free cash flow) and supported by reasonable valuation plus a strong dividend yield. These positives are offset by weak price positioning below major moving averages and some fundamental data volatility alongside slowing growth and slightly lower net income in 2026.
Positive Factors
Conservative balance sheet
Lower leverage and steadily growing equity provide financial resilience for an insurer. This supports claims-paying capacity, investment in member services and technology, and flexibility to manage changes in claims costs or regulation.
Negative Factors
Slowing revenue growth
The marked deceleration reduces the pace at which nib can expand its earnings base and absorb fixed costs. If persistent, slower premium and service growth may limit operating leverage and increase dependence on pricing or efficiency gains.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Lower leverage and steadily growing equity provide financial resilience for an insurer. This supports claims-paying capacity, investment in member services and technology, and flexibility to manage changes in claims costs or regulation.
Read all positive factors
NIB Holdings Ltd (NHF) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$3.26B
Dividend Yield4.12%
Average Volume (3M)1.17M
Price to Earnings (P/E)17.6
Beta (1Y)0.46
Revenue Growth5.26%
EPS Growth-6.54%
CountryAU
Employees1,870
SectorFinancial
Sector Strength70
IndustryInsurance - Specialty
Share Statistics
EPS (TTM)0.38
Shares Outstanding488,912,780
10 Day Avg. Volume1,737,651
30 Day Avg. Volume1,171,624
Financial Highlights & Ratios
PEG Ratio-2.54
Price to Book (P/B)3.02
Price to Sales (P/S)0.90
P/FCF Ratio20.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$7.38Price Target Upside8.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)0.47
Revenue Forecast (FY)AU$3.86B
NIB Holdings Ltd Business Overview & Revenue Model
Company Description
Nib Holdings Limited, through its various subsidiaries, underwrites and distributes private health insurance to a broad clientele, encompassing local residents, international students, and visitors in both Australia and New Zealand. Its business i...
How the Company Makes Money
NIB Holdings Ltd primarily makes money from health insurance underwriting and related insurance distribution.
1) Health insurance premiums (core revenue stream)
- The company’s main revenue comes from premiums paid by members for private health i...
NIB Holdings Ltd Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
81
Very Positive
Cash Flow
70
Positive
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.82B | 3.59B | 3.44B | 3.12B | 2.79B |
| Gross Profit | 399.60M | 3.13B | 3.40B | 3.12B | 2.79B |
| EBITDA | 343.50M | 324.60M | 324.50M | 220.60M | 236.80M |
| Net Income | 187.50M | 199.80M | 185.60M | 191.10M | 133.80M |
Balance Sheet | |||||
| Total Assets | 2.15B | 2.19B | 2.11B | 2.19B | 1.94B |
| Cash, Cash Equivalents and Short-Term Investments | 217.00M | 404.60M | 459.80M | 243.00M | 206.90M |
| Total Debt | 229.50M | 310.20M | 306.80M | 291.80M | 311.70M |
| Total Liabilities | 997.80M | 1.08B | 1.07B | 1.21B | 1.21B |
| Stockholders Equity | 1.14B | 1.11B | 1.04B | 967.20M | 720.10M |
Cash Flow | |||||
| Free Cash Flow | 164.70M | 112.10M | 208.50M | 194.40M | 311.00M |
| Operating Cash Flow | 199.10M | 165.70M | 257.10M | 246.70M | 337.60M |
| Investing Cash Flow | -500.00K | -74.20M | -98.10M | -236.50M | -259.30M |
| Financing Cash Flow | -201.60M | -128.20M | -125.20M | 26.00M | -84.40M |
NIB Holdings Ltd Technical Analysis
Negative
6.82
Price Trends
7.02
Negative
6.77
Negative
6.54
Positive
Market Momentum
-0.12
Positive
42.14
Neutral
20.79
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NHF, the sentiment is Negative. The current price of 6.82 is below the 20-day moving average (MA) of 6.89, below the 50-day MA of 7.02, and above the 200-day MA of 6.54, indicating a neutral trend. The MACD of -0.12 indicates Positive momentum. The RSI at 42.14 is Neutral, neither overbought nor oversold. The STOCH value of 20.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:NHF.
NIB Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | AU$120.94M | 8.56 | 14.18% | ― | 12.24% | 83.56% | |
77 Outperform | AU$18.82B | 18.72 | 14.06% | 3.98% | 9.36% | -24.51% | |
73 Outperform | AU$33.79B | 11.24 | 18.63% | 4.91% | 3.37% | 6.40% | |
69 Neutral | AU$12.83B | 20.26 | 26.74% | 4.12% | 9.29% | 27.49% | |
68 Neutral | AU$3.26B | 17.58 | 16.75% | 4.12% | 5.26% | -6.54% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | AU$20.53B | 20.18 | 10.06% | 3.42% | -2.94% | -31.48% |
* Financial Sector Average
AU:NHF
NIB Holdings Ltd
6.68
-0.26
-3.76%
AU:IAG
Insurance Australia Group Limited
8.05
-0.10
-1.23%
AU:MPL
Medibank Private
4.66
-0.03
-0.58%
AU:QBE
QBE Insurance Group Limited
22.62
2.84
14.36%
AU:SUN
Suncorp Group
19.37
-0.63
-3.15%
AU:NOL
NobleOak Life Ltd
1.30
-0.31
-19.50%
NIB Holdings Ltd Corporate Events
NIB lifts FY26 profit, boosts dividend as digital and international growth drive results
Aug 23, 2026
NIB Holdings reported FY26 group revenue of $3.8 billion, up 6.2%, and underlying operating profit of $260.9 million, up 9.1%, driven by disciplined growth in Australian residents, strong international performance, a sharp recovery in New Zealand ...
NIB Holdings Updates Corporate Governance Disclosures for FY2026
Aug 23, 2026
NIB Holdings has lodged its updated corporate governance statement for the year ended 30 June 2026, confirming compliance with ASX Listing Rules on governance disclosure. The statement, approved by the board and available on the company’s we...
NIB Holdings Declares AUD 0.21 Interim Dividend for Half-Year to June 2026
Aug 23, 2026
NIB Holdings Limited has declared a fully paid ordinary dividend of AUD 0.21 per share for the six-month period ended 30 June 2026. The distribution will be made to shareholders on 7 October 2026, with the ex-dividend date set for 3 September 2026...
NIB Holdings lifts revenue but profit edges lower as dividends remain fully franked
Aug 23, 2026
NIB Holdings has reported revenue from ordinary activities of $3.8 billion for the year ended 30 June 2026, a 5% increase on the prior year, highlighting solid top-line growth in its health insurance and related income streams. Despite this, net p...
NIB Holdings Reports Lapse of 84,798 Performance Rights
Jul 6, 2026
NIB Holdings Ltd has notified the market of the cessation of 84,798 NHFAL performance rights, which lapsed after the conditional rights to securities failed to meet required performance or vesting conditions by 20 April 2026. The announcement indi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.